Dátum ex-dividendy spoločnosti Adaptimmune Therapeutics Plc
Aká je hodnota metriky Dátum ex-dividendy spoločnosti Adaptimmune Therapeutics Plc?
Hodnota metriky Dátum ex-dividendy spoločnosti Adaptimmune Therapeutics Plc je N/A
Aká je definícia metriky Dátum ex-dividendy?
Dátum ex-dividendy (Ex-dividend date) je dátum, ktorý určuje či budú dividendy vyplatené predávajúcemu alebo kupujúcemu. Vyplatené dividendy za akcie kúpené po ex-dividend dátumom patria novému majiteľovi.
The ex-dividend date or reinvestment date is an investment term involving the timing of payment of dividends on stocks of corporations, income trusts, and other financial holdings. If a sale is before this date, the dividend belongs to the new owner; if on or after the date, the seller is entitled to the dividend. If a stock is purchased on its ex-dividend date or after, the buyer will not receive the next dividend payment. Instead, the seller gets the dividend. If a stock is purchased before the ex-dividend date, the buyer gets the dividend.
Čomu sa venuje spoločnosť Adaptimmune Therapeutics Plc?
adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.